Cargando…
Biomaterials and regenerative medicine in ophthalmology /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Duxford, UK :
Woodhead Publishing is an imprint of Elsevier,
2016.
|
| Colección: | Woodhead Publishing series in biomaterials ;
no. 112. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Title page; Table of Contents; Related titles; Copyright; List of contributors; Woodhead Publishing Series in Biomaterials; 1. An introduction to ophthalmic biomaterials and their role in tissue engineering and regenerative medicine; 1.1. Introduction; 1.2. Development of ophthalmic biomaterials: a brief history; 1.3. Tissue engineering and regenerative medicine in ophthalmology; 1.4. Future trends; Part One. Materials, properties and considerations; 2. The ageing ocular surface: Challenges for biomaterials design and function; 2.1. Introduction; 2.2. Ageing tear film.
- 2.3. Ageing lacrimal functional unit2.4. Compromised ocular surface and healing; 2.5. Future for biomaterials; 2.6. Challenges for biomaterials design and function; 2.7. Conclusions; 3. Ocular biotribology and the contact lens: Surface interactions and ocular response; 3.1. Introduction; 3.2. Coefficient of friction; 3.3. Significance of contact lens and ocular surface interactions; 3.4. Coefficient of friction of contact lenses: material and subject-related variables; 3.5. Future trends and conclusions; 4. Physicochemical properties of hydrogels for use in ophthalmology; 4.1. Introduction.
- 4.2. Water in hydrogels: effects of monomer structure4.3. Effect of hydrogel water content on properties; 4.4. Modified hydrogels; 5. Current concepts in the design of hydrogels as vitreous substitutes; 5.1. Introduction; 5.2. Vitreous humor; 5.3. Design of vitreous substitutes; 5.4. Conclusions and recommendations; 5.5. Future trends; 6. Biomaterials for intraocular sustained drug delivery; 6.1. Introduction; 6.2. Anatomical and physiological specificities of the eye; 6.3. Challenging vitreoretinal diseases and targeted molecules; 6.4. Nonbiodegradable devices; 6.5. Biodegradable devices.
- 6.6. Triamcinolone acetonide crystal suspension6.7. Renexus�: encapsulated cell technology; 6.8. Gelling agents; 6.9. Conclusions and future trends; List of abbreviations; Part Two. Biomaterials for the repair and regeneration of the cornea and ocular surface; 7. Collagen scaffolds for corneal regeneration; 7.1. Introduction; 7.2. Scaffolds derived from decellularized stroma; 7.3. Scaffolds fabricated from polymerized collagen; 7.4. Scaffolds fabricated by cells: the true bottom-up approach; 7.5. Populating the scaffolds; 7.6. Future trends.
- 8. Reconstruction of the ocular surface using biomaterial templates8.1. Introduction; 8.2. Treatment of ocular surface disorders; 8.3. Ex vivo expansion of ocular surface epithelial cells; 8.4. Corneal equivalents as replacements or study models; 8.5. Naturally derived biomaterials as substrata for tissue-engineered epithelial constructs; 8.6. Synthetic biomaterials as substrata for tissue-engineered epithelial constructs; 8.7. Strategies based on thermoresponsive polymers; 8.8. Evaluation of silk proteins as substratum for human limbal epithelial cells; 8.9. Conclusions.